Think You Know NASH? A Quiz-Based Challenge on Current and Emerging Management Strategies

Join us for a fun and interactive CME-certified quiz game symposium highlighting the latest diagnostic resources, emerging and investigational therapies, and expert strategies for improving the care of patients with NASH.

Presented for attendees of the 68th AASLD Annual Meeting (or The Liver Meeting®). This event/function is jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC and supported by Gilead Sciences, Inc. This is not an official function/event of the American Association for the Study of Liver Diseases.


7:30 PM    Registration and Buffet Meal 
8:00 PM    Program Overview
                 Faculty: Stephen A. Harrison, MD, COL (Ret.), FAASLD  
8:15 PM    Quiz Round 1: NASH: The State of the Science
Quentin M. Anstee, BSc, MB BS, PhD, MRCP(UK), FRCP
8:35 PM    Quiz Round 2: Current Management Approaches for the Patient With 
Rohit Loomba, MD, MHSc
9:00 PM    Quiz Round 3: Emerging Directions in the Management of NASH
Stephen A. Harrison, MD, COL (Ret.), FAASLD
9:30 PM    Bonus Round and Question and Answer Session
                 Faculty Panel     
10:00 PM  Adjournment


Date / Time
Event Details


Program Director
Stephen Harrison, MD, COL (Ret.), FAASLD

Visiting Professor of Hepatology 
Radcliffe Department of Medicine
University of Oxford
Oxford, United Kingdom

Quentin Anstee, MD

Professor of Experimental Hepatology  
Consultant Hepatologist 
Institute of Cellular Medicine
Newcastle University
Newcastle Upon Tyne, United Kingdom

Rohit Loomba, MD

Director, NAFLD Research Center
Professor of Medicine
Director of Hepatology
University of California at San Diego
La Jolla, California


Goal Statement
The goal of this activity is to improve participants’ competence in identifying and managing patients with NASH.

Target Audience
This program is intended for hepatologists, gastroenterologists, and other healthcare providers who care for patients with or at risk for NASH.

Learning Objectives

  • Consider key risk factors for development of NAFLD and the pathophysiologic mechanisms that lead to NASH
  • Identify patients at risk for NASH and employ appropriate testing strategies to confirm diagnosis
  • Critically evaluate data on emerging therapies for NASH, including evidence of reversal of fibrosis, safety data, and their potential utility in the treatment of patients with NASH


Accreditation Statement 
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and Clinical Care Options, LLC. Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
Postgraduate Institute for Medicine designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.